Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oxford Pre-cancerous Lymphoproliferative Disorders: Analysis and Interception Study

NCT04023747 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT04023747
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04023747 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oxford Pre-cancerous Lymphoproliferative Disorders: Analysis and Interception Study
Lead sponsor
University of Oxford
Phase
Observational
Overall status
Active, not recruiting
Start date
July 3, 2019
Completion date
October 31, 2025
Enrollment
574 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

pre-cancerous lymphoproliferative disorders